275 related articles for article (PubMed ID: 11891066)
1. Drug delivery to the nail following topical application.
Murdan S
Int J Pharm; 2002 Apr; 236(1-2):1-26. PubMed ID: 11891066
[TBL] [Abstract][Full Text] [Related]
2. Ungual and transungual drug delivery.
Shivakumar HN; Juluri A; Desai BG; Murthy SN
Drug Dev Ind Pharm; 2012 Aug; 38(8):901-11. PubMed ID: 22149347
[TBL] [Abstract][Full Text] [Related]
3. Transungual drug delivery: current status.
Elkeeb R; AliKhan A; Elkeeb L; Hui X; Maibach HI
Int J Pharm; 2010 Jan; 384(1-2):1-8. PubMed ID: 19819318
[TBL] [Abstract][Full Text] [Related]
4. Enhancing the nail permeability of topically applied drugs.
Murdan S
Expert Opin Drug Deliv; 2008 Nov; 5(11):1267-82. PubMed ID: 18976136
[TBL] [Abstract][Full Text] [Related]
5. TranScreen-N: Method for rapid screening of trans-ungual drug delivery enhancers.
Murthy SN; Vaka SR; Sammeta SM; Nair AB
J Pharm Sci; 2009 Nov; 98(11):4264-71. PubMed ID: 19363796
[TBL] [Abstract][Full Text] [Related]
6. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
Elsayed MM
J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
[TBL] [Abstract][Full Text] [Related]
7. Iontophoretic drug delivery across the nail.
Delgado-Charro MB
Expert Opin Drug Deliv; 2012 Jan; 9(1):91-103. PubMed ID: 22149385
[TBL] [Abstract][Full Text] [Related]
8. Insights into drug delivery across the nail plate barrier.
Saner MV; Kulkarni AD; Pardeshi CV
J Drug Target; 2014 Nov; 22(9):769-89. PubMed ID: 24964054
[TBL] [Abstract][Full Text] [Related]
9. 1st meeting on topical drug delivery to the nail.
Murdan S
Expert Opin Drug Deliv; 2007 Jul; 4(4):453-5. PubMed ID: 17683257
[TBL] [Abstract][Full Text] [Related]
10. Recent Patents on Permeation Enhancers for Drug Delivery Through Nails.
Kreutz T; de Matos SP; Koester LS
Recent Pat Drug Deliv Formul; 2019; 13(3):203-218. PubMed ID: 31663846
[TBL] [Abstract][Full Text] [Related]
11. Iontophoresis to Overcome the Challenge of Nail Permeation: Considerations and Optimizations for Successful Ungual Drug Delivery.
Chen K; Puri V; Michniak-Kohn B
AAPS J; 2021 Jan; 23(1):25. PubMed ID: 33439400
[TBL] [Abstract][Full Text] [Related]
12. A platform for predicting and enhancing model drug delivery across the human nail plate.
Vaka SR; Murthy SN; O'Haver JH; Repka MA
Drug Dev Ind Pharm; 2011 Jan; 37(1):72-9. PubMed ID: 20545509
[TBL] [Abstract][Full Text] [Related]
13. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
Bhatt V; Pillai R
J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
[TBL] [Abstract][Full Text] [Related]
14. Transungual delivery: deliberations and creeds.
Thatai P; Sapra B
Int J Cosmet Sci; 2014 Oct; 36(5):398-411. PubMed ID: 24888698
[TBL] [Abstract][Full Text] [Related]
15. Use of in vitro performance models in the assessment of drug delivery across the human nail for nail disorders.
Brown M; Turner R; Wevrett SR
Expert Opin Drug Deliv; 2018 Oct; 15(10):983-989. PubMed ID: 30173543
[TBL] [Abstract][Full Text] [Related]
16. An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates.
McAuley WJ; Jones SA; Traynor MJ; Guesné S; Murdan S; Brown MB
Eur J Pharm Biopharm; 2016 May; 102():178-84. PubMed ID: 26969264
[TBL] [Abstract][Full Text] [Related]
17. A systematic approach to the formulation of anti-onychomycotic nail patches.
Rizi K; Mohammed IK; Xu K; Kinloch AJ; Charalambides MN; Murdan S
Eur J Pharm Biopharm; 2018 Jun; 127():355-365. PubMed ID: 29530581
[TBL] [Abstract][Full Text] [Related]
18. Nail disorders in older people, and aspects of their pharmaceutical treatment.
Murdan S
Int J Pharm; 2016 Oct; 512(2):405-411. PubMed ID: 27180233
[TBL] [Abstract][Full Text] [Related]
19. Management of nail psoriasis by topical drug delivery: a pharmaceutical perspective.
Thatai P; Khan AB
Int J Dermatol; 2020 Aug; 59(8):915-925. PubMed ID: 32239692
[TBL] [Abstract][Full Text] [Related]
20. Treatment and management strategies of onychomycosis.
Aggarwal R; Targhotra M; Kumar B; Sahoo PK; Chauhan MK
J Mycol Med; 2020 Jun; 30(2):100949. PubMed ID: 32234349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
